Deb Harris

Deb Harris is the current head of CMC & Program Management at Lassen Therapeutics. Deb has over 20 years of experience in the biopharmaceutical industry, with a focus on product development and radiopharmaceuticals. Prior to their current position, they served as managing director at BDO USA, LLP, where they helped clients navigate through government contracts and tax laws. Deb also worked as a consultant at BioProcess Technology Consultants, Inc. and Allergan. In their previous positions, they served as vice president & site head, director of operations and project management, and director of product development.

Deb Harris attended the University of California, Irvine from 1988 to 1991, where they earned a Bachelor of Science in Biology. Deb then attended UC Irvine from 1994 to 1997, where they earned a degree in MB&B.

The team of Deb Harris, Head, CMC & Program Management, is responsible for the clinical development and manufacturing of the company's products.